The impact of conversion from Prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function

American Journal of Transplantation

Volumn 11, Issue 9, 2011, Pages 1861-1867

  Momper, J D ^a   Ridenour, T A ^a   Schonder, K S ^a   Shapiro, R ^b   Humar, A ^b   Venkataramanan, R ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Generic substitution; immunosuppression; tacrolimus; transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALEMTUZUMAB; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BASILIXIMAB; BILIRUBIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GENERIC DRUG; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITROGEN; TACROLIMUS; UREA;

ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REDUCTION; DRUG FORMULATION; DRUG MONITORING; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER FUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL;

AGED; DRUGS, GENERIC; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TACROLIMUS;

EID: 80052259219     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03615.x     Document Type: Article

References (29)

1. Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramman R, Jain A,. FK 506 for liver, kidney, and pancreas transplantation. Lancet 1989; 2: 1000-1004. (Pubitemid 19257914)
2. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 1110-1115.
3. Shapiro R, Young JB, Milford EL, Trotter JF, Bustami RT, Leichtman AB,. Immunosuppression: Evolution in practice and trends, 1993-2003. Am J Transplant 2005; 5: 874-886. (Pubitemid 40461261)
4. Shapiro R,. Low toxicity immunosuppressive protocols in renal transplantation. Keio J Med 2004; 53: 18-22. (Pubitemid 38470624)
5. Venkataramanan R, Shaw LM, Sarkozi L, et al,. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients. J Clin Pharmacol 2001; 41: 542-551. (Pubitemid 32381872)
6. Kershner RP, Fitzsimmons WE,. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. Transplantation 1996; 62: 920-926. (Pubitemid 26360352)
7. Jusko WJ, Thomson AW, Fung J, et al,. Consensus document: Therapeutic monitoring of tacrolimus (FK-506). Therapeutic Drug Monitor 1995; 17: 606-614.
8. Approval letter, ANDA 65-461. [cited 2010 November 15]; Available from
9. Kirking DM, Ascione FJ, Gaither CA, Welage LS,. Economics and structure of the generic pharmaceutical industry. J Am Pharm Assoc (Wash) 2001; 41: 578-584.
10. Code of Federal Regulation-21 CFR 320 In., 2010.
11. Prograf (R) [package insert]. Deerfield, IL: Astellas; 2009.
12. Sandoz. The summary results of the Sandoz tacrolimus capsules bioequivalence. Holzkirchen, Germany: Author; 2010.
13. Alloway RR, Isaacs R, Lake K, et al,. Report of the American Society of Transplantation conference on immunosuppressive drugs and the use of generic immunosuppressants. Am J Transplant 2003; 3: 1211-1215. (Pubitemid 37214617)
14. Klintmalm G., 2007 [cited 2010 September 15]; Available from
15. Kasiske BL, Cohen D, Lucey MR, Neylan JF,. Payment for immunosuppression after organ transplantation. American Society of Transplantation. JAMA 2000; 283: 2445-2450. (Pubitemid 30257550)
16. De Geest S, Borgermans L, Gemoets H, et al,. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995; 59: 340-347.
17. Greenstein S, Siegal B,. Compliance and noncompliance in patients with a functioning renal transplant: A multicenter study. Transplantation 1998; 66: 1718-1726. (Pubitemid 29034998)
18. Greenstein S, Siegal B,. Odds probabilities of compliance and noncompliance in patients with a functioning renal transplant: A multicenter study. Transplant Proceed 1999; 31: 280-281. (Pubitemid 29127458)
19. Hilbrands LB, Hoitsma AJ, Koene RA,. Medication compliance after renal transplantation. Transplantation 1995; 60: 914-920.
20. Laederach-Hofmann K, Bunzel B,. Noncompliance in organ transplant recipients: A literature review. Gen Hospital Psychiatry 2000; 22: 412-424.
21. Rovelli M, Palmeri D, Vossler E, Bartus S, Hull D, Schweizer R,. Noncompliance in renal transplant recipients: Evaluation by socioeconomic groups. Transplant Proceed 1989; 21: 3979-3981. (Pubitemid 20280465)
22. Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S,. Noncompliance in organ transplant recipients. Transplantation 1990; 49: 374-377. (Pubitemid 20088179)
23. Siegal B, Greenstein SM,. Profiles of noncompliance in patients with a functioning renal transplant: A multicenter study. Compliance Study Group. Transplant Proceed 1999; 31: 1326-1327. (Pubitemid 29127924)
24. Jorgensen K, Povlsen J, Madsen S, et al,. C2 (2-h) levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal-transplant patients. Nephrol Dial Transplant 2002; 17: 1487-1490.
25. Kimikawa M, Kamoya K, Toma H, Teraoka S,. Effective oral administration of tacrolimus in renal transplant recipients. Clin Transplant 2001; 15: 324-329. (Pubitemid 32936879)
26. Braun F, Schutz E, Peters B, et al,. Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients. Transplant Proceed 2001; 33: 2127-2128. (Pubitemid 33762655)
27. Bottiger Y, Undre NA, Sawe J, Stevenson PJ, Ericzon BG,. Effect of bile flow on the absorption of tacrolimus in liver allograft transplantation. Transplant Proceed 2002; 34: 1544-1545.
28. Wong KM, Shek CC, Chau KF, Li CS,. Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipients. Am J Kidney Dis 2000; 35: 660-666.
29. Tada H, Satoh S, Iinuma M, et al,. Chronopharmacokinetics of tacrolimus in kidney transplant recipients: Occurrence of acute rejection. J Clin Pharmacol 2003; 43: 859-865. (Pubitemid 36886106)